162 related articles for article (PubMed ID: 31096466)
1. High expression of survivin predicts poor prognosis in cervical squamous cell carcinoma treated with paclitaxel and carboplatin.
Zhang Y; Yan H; Li R; Guo Y; Zheng R
Medicine (Baltimore); 2019 May; 98(20):e15607. PubMed ID: 31096466
[TBL] [Abstract][Full Text] [Related]
2. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
[TBL] [Abstract][Full Text] [Related]
3. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
5. Combination of weekly paclitaxel-carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB-IIB cervical cancer.
Maene C; Salihi RR; Van Nieuwenhuysen E; Han SN; Concin N; Vergote I
Int J Gynecol Cancer; 2021 Jun; 31(6):824-828. PubMed ID: 33858952
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer.
Salihi R; Leunen K; Moerman P; Amant F; Neven P; Vergote I
Int J Gynecol Cancer; 2017 Jul; 27(6):1256-1260. PubMed ID: 28574931
[TBL] [Abstract][Full Text] [Related]
7. Influence of serum VEGF levels on therapeutic outcome and diagnosis/prognostic value in patients with cervical cancer.
Du K; Gong HY; Gong ZM
Asian Pac J Cancer Prev; 2014; 15(20):8793-6. PubMed ID: 25374209
[TBL] [Abstract][Full Text] [Related]
8. The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas.
Tian XP; Qian D; He LR; Huang H; Mai SJ; Li CP; Huang XX; Cai MY; Liao YJ; Kung HF; Zeng YX; Xie D
Cancer Lett; 2014 Oct; 353(1):104-14. PubMed ID: 25045845
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant paclitaxel and cisplatin in uterine cervical cancer: long-term results.
Park DC; Suh MJ; Yeo SG
Int J Gynecol Cancer; 2009 Jul; 19(5):943-7. PubMed ID: 19574789
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer.
Nagao S; Yamamoto K; Oishi T; Yamaguchi S; Takehara K; Shimada M; Kigawa J
Int J Clin Oncol; 2021 Jan; 26(1):207-215. PubMed ID: 32960420
[TBL] [Abstract][Full Text] [Related]
11. Prediction of progression-free survival and response to paclitaxel plus carboplatin in patients with recurrent or advanced cervical cancer.
Hisamatsu T; Mabuchi S; Yoshino K; Fujita M; Enomoto T; Hamasaki T; Kimura T
Int J Gynecol Cancer; 2012 May; 22(4):623-9. PubMed ID: 22343974
[TBL] [Abstract][Full Text] [Related]
12. Elevated CTHRC1 expression is an indicator for poor prognosis and lymph node metastasis in cervical squamous cell carcinoma.
Li N; Chen L; Liu C; Jiang Y; Rong J
Hum Pathol; 2019 Mar; 85():235-241. PubMed ID: 30381261
[TBL] [Abstract][Full Text] [Related]
13. Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.
Yang H; Hu H; Gou Y; Hu Y; Li H; Zhao H; Wang B; Li P; Zhang Z
Int J Clin Oncol; 2018 Apr; 23(2):321-328. PubMed ID: 29101499
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
Li D; Xu XX; Yan DD; Yuan SH; Lou HM
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
[No Abstract] [Full Text] [Related]
15. Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.
Salihi R; Leunen K; Van Limbergen E; Moerman P; Neven P; Vergote I
Gynecol Oncol; 2015 Dec; 139(3):447-51. PubMed ID: 26050921
[TBL] [Abstract][Full Text] [Related]
16. Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer?
Lee DW; Lee KH; Lee JW; Park ST; Park JS; Lee HN
Int J Gynecol Cancer; 2013 Sep; 23(7):1303-10. PubMed ID: 23881101
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Expression and Prognostic Significance of CD97 and its Ligand DAF in Human Cervical Squamous Cell Carcinoma.
He Y; Wang W; Xu L; Li L; Liu J; Feng M; Bu H
Int J Gynecol Pathol; 2015 Sep; 34(5):473-9. PubMed ID: 26107567
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of neoadjuvant paclitaxel-carboplatin chemotherapy followed by radical hysterectomy compared to radical hysterectomy alone in bulky stage IB2-IIA cervical cancer.
Prueksaritanond N; Chaisarn P; Yanaranop M
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S55-61. PubMed ID: 22619888
[TBL] [Abstract][Full Text] [Related]
19. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
[TBL] [Abstract][Full Text] [Related]
20. Uncovering PD-L1 and CD8
Chen J; Gu P; Wu H
Biomed Res Int; 2020; 2020():8164365. PubMed ID: 32884946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]